Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

374 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT07036523

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Florida Gainesville, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 46 locations
View Trial Details
Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

NCT06968845

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Paradigm Clinical Research Centers, LLC San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 30 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View Trial Details
Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 373 locations
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 54 locations
View Trial Details
Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

NCT07652658

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Loma Linda, California, United States
View all 190 locations
View Trial Details

Related conditions